journal article·2017-05-19

An update clinical application of amniotic fluid-derived stem cells (AFSCs) in cancer cell therapy and tissue engineering

Shiva Gholizadeh-Ghaleh Aziz, Ezzatollah Fathi, Mohammad Rahmati-Yamchi, Abolfazl Akbarzadeh, Zahra Fardyazar, Maryam Pashaiasl

Publisher page

Abstract

Recent studies have elucidated that cell-based therapies are promising for cancer treatments. The human amniotic fluid stem (AFS) cells are advantageous cells for such therapeutic schemes that can be innately changed to express therapeutic proteins. HAFSCs display a natural tropism to cancer cells in vivo. They can be useful in cancer cells targeting. Moreover, they are easily available from surplus diagnostic samples during pregnancy and less ethical and legal concern are associated with the collection and application than other putative cells are subjected. This review will designate representatives of amniotic fluid and stem cell derived from amniotic fluid. For this propose, we collect state of human AFS cells data applicable in cancer therapy by dividing this approach into two main classes (nonengineered and engineered based approaches). Our study shows the advantage of AFS cells over other putative cells types in terms differentiation ability to a wide range of cells by potential and effective use in preclinical studies for a variety of diseases. This study has shown the elasticity of human AFS cells and their favorable potential as a multipotent cell source for regenerative stem cell therapy and capable of giving rise to multiple lineages including such as osteoblasts and adipocyte.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Mesenchymal stem cell research · Pluripotent Stem Cells Research · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Women?s Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

Department of Molecular Medicine, School of Advanced Medical Science, Tabriz University of Medical Science, Tabriz, Iran;

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran;

Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Iran;

Department of Clinical Biochemistry, Tabriz University of Medical Science, Tabriz, Iran;

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

References (97)

Show source-provided references
1. 10.1093/jnci/90.5.37010.1093/jnci/90.5.370 ↗
2. 10.1038/sj.cgt.770019110.1038/sj.cgt.7700191 ↗
3. 10.1089/scd.2011.015110.1089/scd.2011.0151 ↗
4. 10.1089/scd.2010.042410.1089/scd.2010.0424 ↗
5. 10.1007/s12015-010-9200-z10.1007/s12015-010-9200-z ↗
6. 10.1038/sj.cr.731004310.1038/sj.cr.7310043 ↗
7. 10.1038/sj.cr.731004310.1038/sj.cr.7310043 ↗
8. Brace RA. · Semin Perinatol · 1986 · 10 · 103
9. 10.1016/S1473-3099(16)00095-510.1016/S1473-3099(16)00095-5 ↗
10. 10.1007/s11892-015-0616-310.1007/s11892-015-0616-3 ↗
11. 10.1016/j.yjmcc.2006.12.00810.1016/j.yjmcc.2006.12.008 ↗
12. 10.1007/s11626-013-9662-910.1007/s11626-013-9662-9 ↗
13. 10.1016/j.cellbi.2007.01.03710.1016/j.cellbi.2007.01.037 ↗
14. 10.1016/j.juro.2009.11.00610.1016/j.juro.2009.11.006 ↗
15. 10.1038/nbt127410.1038/nbt1274 ↗
16. 10.1016/j.juro.2006.09.10310.1016/j.juro.2006.09.103 ↗
17. 10.1387/ijdb.092935md10.1387/ijdb.092935md ↗
18. 10.1016/0002-9378(76)90564-010.1016/0002-9378(76)90564-0 ↗
19. 10.1016/S0076-6879(06)20013-210.1016/S0076-6879(06)20013-2 ↗
20. 10.1016/j.bpobgyn.2004.07.00110.1016/j.bpobgyn.2004.07.001 ↗
21. 10.15283/ijsc.2015.8.2.11510.15283/ijsc.2015.8.2.115 ↗
22. 10.1093/oxfordjournals.bmb.a07184710.1093/oxfordjournals.bmb.a071847 ↗
23. Graham CD · Curr Protoc Stem Cell Biol · 2007 · 1E. 2.1
24. 10.1517/14712598.8.3.25510.1517/14712598.8.3.255 ↗
25. 10.1038/nrd357710.1038/nrd3577 ↗
26. 10.1007/s10456-006-9040-210.1007/s10456-006-9040-2 ↗
27. Han Y · Eur Rev Med Pharmacol Sci · 2012 · 16 · 1873
28. 10.2353/ajpath.2010.09124510.2353/ajpath.2010.091245 ↗
29. 10.1089/hum.2015.07210.1089/hum.2015.072 ↗
30. 10.1038/nrc210810.1038/nrc2108 ↗
31. 10.1016/S0091-679X(08)61362-X10.1016/S0091-679X(08)61362-X ↗
32. 10.1634/stemcells.2004-005810.1634/stemcells.2004-0058 ↗
33. 10.1007/s11033-011-0760-z10.1007/s11033-011-0760-z ↗
34. 10.1007/s12272-012-0207-710.1007/s12272-012-0207-7 ↗
35. 10.1038/cgt.2012.3010.1038/cgt.2012.30 ↗
36. 10.1038/cgt.2012.1510.1038/cgt.2012.15 ↗
37. 10.1053/jpsu.2001.2794510.1053/jpsu.2001.27945 ↗
38. 10.1634/stemcells.2005-034210.1634/stemcells.2005-0342 ↗
39. 10.1111/j.1365-2184.2007.00414.x10.1111/j.1365-2184.2007.00414.x ↗
40. 10.1111/j.1349-7006.2009.01485.x10.1111/j.1349-7006.2009.01485.x ↗
41. Kim SU · Anticancer Res · 2011 · 31 · 1249
42. 10.3727/09636890878415390410.3727/096368908784153904 ↗
43. 10.1007/s10735-007-9118-110.1007/s10735-007-9118-1 ↗
44. 10.1155/2015/75251010.1155/2015/752510 ↗
45. 10.1097/PSY.000000000000013010.1097/PSY.0000000000000130 ↗
46. Lai E. 2010. Regenerative medicine at early echelons: changing medical care & outcomes. DTIC Document.
47. 10.1002/dvdy.2047110.1002/dvdy.20471 ↗
48. 10.1038/gt.2015.9010.1038/gt.2015.90 ↗
49. 10.1371/journal.pone.012335010.1371/journal.pone.0123350 ↗
50. 10.1111/joa.1228310.1111/joa.12283 ↗
51. 10.1016/j.bpobgyn.2015.08.00910.1016/j.bpobgyn.2015.08.009 ↗
52. Luo H · Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi · 2011 · 25 · 144
53. 10.3727/096368910X50449610.3727/096368910X504496 ↗
54. 10.1007/s00441-014-1840-x10.1007/s00441-014-1840-x ↗
55. 10.1002/hep.2425510.1002/hep.24255 ↗
56. 10.1038/nature0926210.1038/nature09262 ↗
57. Minei LJ · Obstet Gynecol · 1976 · 48 · 177
58. Moorefield EC · 2010 · 113
59. 10.3727/096368914X68350210.3727/096368914X683502 ↗
60. 10.1007/978-1-4939-1785-3_1210.1007/978-1-4939-1785-3_12 ↗
61. 10.2217/17460751.4.2.27510.2217/17460751.4.2.275 ↗
62. 10.1016/j.gene.2015.12.02310.1016/j.gene.2015.12.023 ↗
63. 10.1016/S0091-679X(08)00005-810.1016/S0091-679X(08)00005-8 ↗
64. 10.1371/journal.pone.000935710.1371/journal.pone.0009357 ↗
65. 10.1186/1471-2121-11-7910.1186/1471-2121-11-79 ↗
66. 10.4252/wjsc.v7.i4.68110.4252/wjsc.v7.i4.681 ↗
67. 10.1073/pnas.080046710510.1073/pnas.0800467105 ↗
68. 10.2310/6650.2005.0504310.2310/6650.2005.05043 ↗
69. Priest R · Lab Invest · 1978 · 39 · 106
70. Prusa AR · . Med. Sci. Monit · 2002 · 8 · RA253
71. 10.1016/j.ajog.2003.12.01410.1016/j.ajog.2003.12.014 ↗
72. 10.1093/humrep/deg27910.1093/humrep/deg279 ↗
73. Rezania A. · 2015
74. 10.1097/WCO.0b013e3282f132fc10.1097/WCO.0b013e3282f132fc ↗
75. 10.1089/scd.2007.003610.1089/scd.2007.0036 ↗
76. 10.1182/blood-2003-04-129110.1182/blood-2003-04-1291 ↗
77. Schiller PC, D’Ippolito G. 2014. Non-expanded post-natal multilineage-inducible cells. Google Patents.
78. 10.3324/haematol.1186910.3324/haematol.11869 ↗
79. 10.1097/GCO.0b013e32834457b110.1097/GCO.0b013e32834457b1 ↗
80. 10.1158/1538-7445.AM2015-506810.1158/1538-7445.AM2015-5068 ↗
81. 10.5966/sctm.2012-008810.5966/sctm.2012-0088 ↗
82. 10.4161/org.2519710.4161/org.25197 ↗
83. 10.1002/9780470151808.sc01e02s110.1002/9780470151808.sc01e02s1 ↗
84. 10.1016/j.cell.2007.11.01910.1016/j.cell.2007.11.019 ↗
85. 10.1254/jphs.CR007003410.1254/jphs.CR0070034 ↗
86. Todorov P · C R Acad Bulg Sci · 2015 · 68 · 65
87. 10.1038/nm144810.1038/nm1448 ↗
88. 10.1038/nbt0308-26910.1038/nbt0308-269 ↗
89. 10.1093/humrep/deh27910.1093/humrep/deh279 ↗
90. 10.1038/sj.jp.721129010.1038/sj.jp.7211290 ↗
91. 10.1634/stemcells.2006-082510.1634/stemcells.2006-0825 ↗
92. 10.1089/ten.2006.031310.1089/ten.2006.0313 ↗
93. 10.1016/j.tox.2014.12.01010.1016/j.tox.2014.12.010 ↗
94. Yi BR · Int J Oncol · 2011 · 39 · 833
95. 10.1136/gutjnl-2012-30373510.1136/gutjnl-2012-303735 ↗
96. 10.1371/journal.pone.001678910.1371/journal.pone.0016789 ↗
97. 10.1007/s00404-014-3231-710.1007/s00404-014-3231-7 ↗